Perjeta 420 MG/14 ML vial 14ML
Ended Awarded
- Contract number
- SPE2DX25F6ACD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $27,344
Award facts
- Contract value 100% obligated
- $27,343.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $27,343.62 on July 28, 2025, for the supply of Perjeta 420 mg/14 mL vials. The contract, which carries no set-aside designation, is funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by August 18, 2025. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to issue firm fixed-price orders for comprehensive pharmaceutical supplies supporting military health facilities worldwide.
As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has established a robust portfolio of contract awards delivering specialized medications and biologics to Department of Defense healthcare sites. Perjeta, a monoclonal antibody used in oncology treatment regimens, represents the type of specialty pharmaceutical products the company routinely distributes through its DLA relationship. The firm's consistent success in federal procurement, leveraging its woman-owned small business status and extensive pharmaceutical distribution capabilities, positions it as a key provider of prescription drugs, biologics, and medical consumables to military health facilities across the nation.
Quick answers
Who was awarded contract SPE2DX25F6ACD?
SPE2DX25F6ACD was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 28, 2025.
How much is contract SPE2DX25F6ACD worth?
The government has obligated $27,344 on SPE2DX25F6ACD.
Is contract SPE2DX25F6ACD an order under another contract?
Yes. SPE2DX25F6ACD is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6ACD competed?
The extent of competition for SPE2DX25F6ACD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award